Targeting the APC/C has shown potent anti-tumor capacity and the combination of spindle poisons with a proteasome inhibitor or direct inhibitors of the APC/C and Mcl-1 seems a promising approach to improve treatment response in different solid tumors, even though they act entity-dependent at different cell cycle phases. This evidence concerns the gene APC and neoplasm.